Bir Dawn Carter
- SEC CIK
- 0001688712
No open-market purchases or sales filed in the past year.
Current role at each company
- GERN Geron CorpDirectoras of May 26, 2026
- SLNO Soleno Therapeutics IncDirectoras of May 18, 2026
- FLNA Filana Therapeutics, Inc.Directoras of Oct 22, 2025
- RETA Reata Pharmaceuticals IncChief Commercial Officeras of Sep 26, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Bir Dawn Carter as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
RETA Reata Pharmaceuticals Inc
Chief Commercial Officer6 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 17, 2023 (view filing) | Aug 15-16 | 2 days | Bir Dawn CarterChief Commercial Officer | SSaleClass A common stock | −1.21K | $168.81 | −$203.4K | −3.4%33.8K after | 2 lots |
| Aug 1, 2023 (view filing) | Jul 28 | 4 days | Bir Dawn CarterChief Commercial Officer | SSaleClass A common stock | −40.0K | $164.54 | −$6.58M | −53.3%35.0K after | 10b5-1 |
| May 17, 2023 (view filing) | May 15-16 | 2 days | Bir Dawn CarterChief Commercial Officer | SSaleClass A common stock | −1.31K | $83.78 | −$109.8K | −4.1%30.9K after | 2 lots |
| Mar 15, 2023 (view filing) | Mar 13 | 2 days | Bir Dawn CarterChief Commercial Officer | SSaleClass A common stock | −9.32K | $86.77 | −$808.4K | −22.4%32.2K after | |
| Mar 8, 2023 (view filing) | Mar 6-7 | 2 days | Bir Dawn CarterChief Commercial Officer | SSaleClass A common stock | −97.0K | $87.67 | −$8.50M | −70.0%41.5K after | 5 lots |
| Mar 6, 2023 (view filing) | Mar 3 | 3 days | Bir Dawn CarterChief Commercial Officer | SSaleClass A common stock | −2.17K | $88.25 | −$191.1K | −4.3%48.5K after |